Resonance Health Limited Appendix 4E Preliminary final report 1. Company details Name of entity: Resonance Health Limited ABN: 96 006 762 492 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Results for...
Appendix 4E, Full Year Statutory Accounts & Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Resonance Health
- FY26 Full Year Results Webinar
- Cessation of Quarterly Reporting
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
- Profit Guidance Upgrade
- Receipt of R&D Tax Incentive Refund
Later from Resonance Health
- FY26 Full Year Results & FY27 Guidance Investor Presentation
- FY26 Full Year Results & Investor Webinar
- Appendix 4G & Corporate Governance Statement
- Global Strategic Alliance & MSA with Image Analysis Group
- Change in Substantial Holding
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health